36 min listen
Antibodies For Severe Allergies With IgGenix's Jessica Grossman, M.D.
Antibodies For Severe Allergies With IgGenix's Jessica Grossman, M.D.
ratings:
Length:
39 minutes
Released:
Apr 4, 2022
Format:
Podcast episode
Description
In this wide-ranging discussion, IgGenix CEO Jessica Grossman, M.D. discusses the application of and market opportunity for antibody therapy for severe allergies, the gender gap in the biopharma c-suite, why women work harder than men, what it means to be a female biopharma leader, and IgGenix's approach at isolating and re-engineering allergen-specific IgE antibodies into IgG antibodies designed to alleviate — and possibly prevent — allergic cascade.
Released:
Apr 4, 2022
Format:
Podcast episode
Titles in the series (100)
002: The Biopharma Exit Strategy With Dr. Francois Nader by Business Of Biotech